Mereo BioPharma Group plc (MREO)
NASDAQ·Healthcare·Biotechnology
$0.29
+4.20%
Mkt Cap $62.52M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$3.25
Range $0.50 – $8.00
Implied Upside
+1002.1%
Consensus $3.25 vs current $0.29
NASDAQ·Healthcare·Biotechnology
$0.29
+4.20%
Mkt Cap $62.52M
No recent rating data.
Price Target (10 analysts)
$3.25
Range $0.50 – $8.00
+1002.1%
Consensus $3.25 vs current $0.29